ES2141049A1 - Formulaciones farmaceuticas en aerosol que contienen trigliceridos de cadena media como surfactantes. - Google Patents

Formulaciones farmaceuticas en aerosol que contienen trigliceridos de cadena media como surfactantes.

Info

Publication number
ES2141049A1
ES2141049A1 ES009800519A ES9800519A ES2141049A1 ES 2141049 A1 ES2141049 A1 ES 2141049A1 ES 009800519 A ES009800519 A ES 009800519A ES 9800519 A ES9800519 A ES 9800519A ES 2141049 A1 ES2141049 A1 ES 2141049A1
Authority
ES
Spain
Prior art keywords
surfactants
pharmaceutical formulations
chain triglycerides
aerosol pharmaceutical
contain medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES009800519A
Other languages
English (en)
Other versions
ES2141049B1 (es
Inventor
Pratmarso Alejandra Calzada
Maneses M Jesus Villazon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aldo Union S A Lab
Original Assignee
Aldo Union S A Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aldo Union S A Lab filed Critical Aldo Union S A Lab
Priority to ES9800519A priority Critical patent/ES2141049B1/es
Publication of ES2141049A1 publication Critical patent/ES2141049A1/es
Application granted granted Critical
Publication of ES2141049B1 publication Critical patent/ES2141049B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Abstract

La formulación comprende un medicamento, un propelente hidrofluoro- carbonada, un surfactante constituido por un triglicérido de cadena media de fórmula (I), en la que R{sub,l , R{sub,2 , y R{sub,3 que pueden ser iguales o diferentes, representan un grupo funcional alquilo de 5 a 11 átomos de carbono, y un cosolvente de mayor polaridad que el propelente. En una realización concreta el surfactante es un éster mixto de los ácidos caprílico y cáprico. Esta formulación es adecuada para la administración de medicamentos por vía inhalatoria.
ES9800519A 1998-03-11 1998-03-11 Formulaciones farmaceuticas en aerosol que contienen trigliceridos de cadena media como surfactantes. Expired - Fee Related ES2141049B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9800519A ES2141049B1 (es) 1998-03-11 1998-03-11 Formulaciones farmaceuticas en aerosol que contienen trigliceridos de cadena media como surfactantes.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9800519A ES2141049B1 (es) 1998-03-11 1998-03-11 Formulaciones farmaceuticas en aerosol que contienen trigliceridos de cadena media como surfactantes.

Publications (2)

Publication Number Publication Date
ES2141049A1 true ES2141049A1 (es) 2000-03-01
ES2141049B1 ES2141049B1 (es) 2000-10-16

Family

ID=8303068

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9800519A Expired - Fee Related ES2141049B1 (es) 1998-03-11 1998-03-11 Formulaciones farmaceuticas en aerosol que contienen trigliceridos de cadena media como surfactantes.

Country Status (1)

Country Link
ES (1) ES2141049B1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7566445B1 (en) 1996-08-01 2009-07-28 Norton Healthcare Limited Medicinal aerosols and methods of delivery thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2045470T3 (es) * 1988-12-06 1994-01-16 Riker Laboratories Inc Formulaciones medicinales en aerosol.
WO1996019198A1 (en) * 1994-12-22 1996-06-27 Astra Aktiebolag Aerosol drug formulations

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2045470T3 (es) * 1988-12-06 1994-01-16 Riker Laboratories Inc Formulaciones medicinales en aerosol.
WO1996019198A1 (en) * 1994-12-22 1996-06-27 Astra Aktiebolag Aerosol drug formulations

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7566445B1 (en) 1996-08-01 2009-07-28 Norton Healthcare Limited Medicinal aerosols and methods of delivery thereof
US9650203B2 (en) 1996-08-01 2017-05-16 Norton Healthcare Limited Medicinal aerosols and methods of delivery thereof

Also Published As

Publication number Publication date
ES2141049B1 (es) 2000-10-16

Similar Documents

Publication Publication Date Title
NZ330369A (en) aqueous medicaments containing 9-hydroxy-risperidone fatty acid ester
NZ509418A (en) Pharmaceutical formulations for aerosols with two or more active substances
DK1173153T3 (da) Orale farmaceutiske præparater, som indeholder langkædede triglycerider og lipofile overfladeaktive midler
HK1028877A1 (en) Self-emulsifying formulation for lipophilic compounds
CA2294031A1 (en) SELF-EMULSIFYING FORMULATION FOR LIPOPHILIC COMPOUNDS
PL310344A1 (en) Lyposome containing therapeutic preparations for administration by injection
EP1455763A4 (en) FORMULATION OF ORAL ADMINISTRATION GELULA HAVING INCREASED PHYSICAL STABILITY
CA2156288A1 (en) Glycerol derivative, device and pharmaceutical composition
HUP0204137A2 (hu) Fulvesztrantot tartalmazó gyógyászati készítmény
PL318560A1 (en) Novel orally administered preparations containing cyclosporin of simple composition and high bioavailability
HK1033263A1 (en) Pharmaceutical compositions capable of being gelled
DE69427708T2 (de) Stabilisierte arzneizusammensetzung enthaltend 10-hydroxy-7-ethylcamptothecin als lakton-verbindung
KR970706021A (ko) N-치환-o-톨루이딘유도체로 이루어진 약용배합제 및 경피흡수형제제(MEDICINAL ADJUVANTS CONSISTIONG OF AN N-SUBSTITUED-o-TOLUIDING DERIVANTIVE, AND PERCUTANEOUSLY ABSORBALE PREPARATIONS COMPRISING THE ADJUVANTS)
TW221378B (es)
ES2134237T3 (es) Composiciones farmaceuticas que contienen acido ursodesoxicolico.
MX2007004105A (es) Capsulas de lercanidipino.
ES2141049A1 (es) Formulaciones farmaceuticas en aerosol que contienen trigliceridos de cadena media como surfactantes.
IT1293835B1 (it) Composizioni farmaceutiche orali in forma solida a cessione modulata contenenti nicorandil e procedimento per la loro preparazione
MY130474A (en) Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20000301

Kind code of ref document: A1

Effective date: 20000301

FD2A Announcement of lapse in spain

Effective date: 20161214